The novel hamster-adapted SARS-CoV-2 Delta variant may be selectively advantaged in humans. - Archive ouverte HAL Access content directly
Journal Articles Journal of Infection Year : 2022

The novel hamster-adapted SARS-CoV-2 Delta variant may be selectively advantaged in humans.

(1) , (2, 3, 4) , (1) , (5, 6)
1
2
3
4
5
6

Dates and versions

hal-03818205 , version 1 (01-11-2022)

Identifiers

Cite

Jacques Fantini, Christian Devaux, Nouara Yahi, Roger Frutos. The novel hamster-adapted SARS-CoV-2 Delta variant may be selectively advantaged in humans.. Journal of Infection, 2022, 84 (5), pp.e53-e54. ⟨10.1016/j.jinf.2022.03.001⟩. ⟨hal-03818205⟩
5 View
1 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More